Acrivon Therapeutics (ACRV) Institutional Ownership $5.65 -0.13 (-2.25%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Acrivon Therapeutics (NASDAQ:ACRV)CurrentInstitutional OwnershipPercentage71.62%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$20.75MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$674.56K Get ACRV Insider Trade Alerts Want to know when executives and insiders are buying or selling Acrivon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACRV Institutional Buying and Selling by Quarter Acrivon Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails12/26/2024JPMorgan Chase & Co.33,991$238K0.0%+548.3%0.109% 12/13/2024Exome Asset Management LLC116,757$817K0.5%N/A0.375% 11/19/2024Barclays PLC33,306$233K0.0%+51.2%0.107% 11/16/2024Geode Capital Management LLC302,103$2.12M0.0%-2.0%0.975% 11/15/2024Barclays PLC33,306$233K0.0%+51.2%0.108% 11/15/2024State Street Corp225,896$1.58M0.0%+26.4%0.729% 11/12/2024Charles Schwab Investment Management Inc.116,253$814K0.0%-19.2%0.375% 10/10/2024Exchange Traded Concepts LLC20,348$142K0.0%-52.5%0.066% 8/16/2024Perceptive Advisors LLC5,360,858$31.09M0.7%+78.2%17.362% 8/14/2024Marshall Wace LLP948,866$5.50M0.0%+58.8%3.073% Get the Latest News and Ratings for ACRV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acrivon Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/13/2024Sands Capital Ventures LLC2,122,605$12.31M4.1%+28.4%6.874% 8/12/2024XTX Topco Ltd10,493$61K0.0%N/A0.034% 8/9/2024Renaissance Technologies LLC54,500$316K0.0%-46.9%0.177% 8/9/2024Dimensional Fund Advisors LP10,066$58K0.0%N/A0.033% 8/1/2024Rhumbline Advisers16,209$94K0.0%+48.9%0.052% 7/26/2024Bank of New York Mellon Corp36,632$212K0.0%+50.1%0.119% 5/15/2024Baker BROS. Advisors LP52,885$378K0.0%N/A0.234% 5/14/2024American International Group Inc.6,016$43K0.0%+39.2%0.027% 5/10/2024Vanguard Group Inc.507,185$3.63M0.0%+6.6%2.241% 1/5/2024Exchange Traded Concepts LLC13,289$65K0.0%+34.0%0.060% 11/13/2023Federated Hermes Inc.226,375$2.16M0.0%-25.6%1.020% 9/21/2023Barclays PLC14,263$184K0.0%-16.0%0.065% 8/10/2023AAF Wealth Management LLC10,678$138K0.1%N/A0.049% 7/20/2023Exchange Traded Concepts LLC11,709$152K0.0%N/A0.053% 5/8/2023Federated Hermes Inc.613,625$7.79M0.0%-25.5%2.798% 2/16/2023HealthCor Management L.P.284,201$3.27M3.0%N/A1.360% 2/14/2023RA Capital Management L.P.4,810,508$55.42M1.1%N/A23.028% 2/13/2023Sands Capital Ventures LLC1,652,605$19.04M5.2%N/A7.913% 2/10/2023NEA Management Company LLC481,677$4.44M0.2%N/A2.306% 2/1/2023Bank of Montreal Can42,444$545K0.0%N/A0.203% (Data available from 1/1/2016 forward) ACRV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACRV shares? During the previous two years, 24 institutional investors and hedge funds held shares of Acrivon Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($55.42M), Perceptive Advisors LLC ($31.09M), Sands Capital Ventures LLC ($12.31M), Marshall Wace LLP ($5.50M), NEA Management Company LLC ($4.44M), Vanguard Group Inc. ($3.63M), and HealthCor Management L.P. ($3.27M).Learn more on ACRV's institutional investors. What percentage of Acrivon Therapeutics stock is owned by institutional investors? 71.62% of Acrivon Therapeutics stock is owned by institutional investors. Learn more on ACRV's institutional investor holdings. Which institutional investors have been buying Acrivon Therapeutics stock? Of the 20 institutional investors that purchased Acrivon Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.81M), Perceptive Advisors LLC ($2.35M), Sands Capital Ventures LLC ($2.12M), NEA Management Company LLC ($481.68K), Marshall Wace LLP ($351.40K), HealthCor Management L.P. ($284.20K), and Exome Asset Management LLC ($116.76K). How much institutional buying is happening at Acrivon Therapeutics? Institutional investors have bought a total of 10,810,759 shares in the last 24 months. This purchase volume represents approximately $104.83M in transactions. Which Acrivon Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Acrivon Therapeutics stock in the last 24 months: Federated Hermes Inc. ($287.71K), Renaissance Technologies LLC ($48.10K), Charles Schwab Investment Management Inc. ($27.71K), Exchange Traded Concepts LLC ($22.52K), Geode Capital Management LLC ($6.29K), and Barclays PLC ($2.72K). How much institutional selling is happening at Acrivon Therapeutics? Institutional investors have sold a total of 395,042 shares in the last 24 months. This volume of shares sold represents approximately $4.12M in transactions. Related Companies Dianthus Therapeutics Institutional Ownership CorMedix Institutional Ownership uniQure Institutional Ownership 89bio Institutional Ownership Cullinan Therapeutics Institutional Ownership LENZ Therapeutics Institutional Ownership Pharming Group Institutional Ownership Arbutus Biopharma Institutional Ownership Immunome Institutional Ownership Evolus Institutional Ownership This page (NASDAQ:ACRV) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acrivon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACRV Stock Alerts